Literature DB >> 26759224

Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort.

Luiza F Rocha1, Ana Paula Luppino Assad2, Roberta G Marangoni3, Ana Paula Toledo Del Rio4, João Francisco Marques-Neto4, Percival D Sampaio-Barros5,6.   

Abstract

The objective of this study is to describe the characteristics of patients with Erasmus syndrome (ES) in a large SSc Brazilian cohort. Nine hundred and forty-seven SSc patients attended at the Scleroderma Outpatient Clinic at two academic medical centers in Brazil and classified as SSc according to the ACR/EULAR criteria were retrospectively studied. Information on demographics, clinical, and laboratory features was obtained by chart review. ES patients had their HLA class II characterized by PCR-SSO method as available. Among the 947 SSc patients studied, nine (0.9 %) had ES. These ES patients were predominantly male (78 %) and smokers (68 %) and presented diffuse SSc (67 %). Mean time of occupational exposure to silica was 13.7 years, with mean age at onset of 47 years. Previous history of tuberculosis was referred by 33 % of the ES patients. All the ES patients presented Raynaud's phenomenon, esophageal involvement, and interstitial lung disease (ILD). Antinuclear antibodies were present in all the ES patients, while anti-topoisomerase I was positive in 44 % and no patient had anticentromere antibody. Three different HLA-DQB alleles (0506, 0305, and 0303) were observed. Compared to non-ES cases, patients with ES were associated with male gender (p < 0.001), diffuse SSc (p < 0.05), ILD (p < 0.05), positive anti-topoisomerase I antibodies (p < 0.05), and death (p < 0.05). Multivariate analysis did not confirm that silicosis is an independent risk factor for SSc. To conclude, ES was rare in this large SSc cohort, although associated with a bad prognosis.

Entities:  

Keywords:  Erasmus syndrome; Occupational exposure; Silicosis; Systemic sclerosis

Mesh:

Substances:

Year:  2016        PMID: 26759224     DOI: 10.1007/s00296-015-3412-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Male systemic sclerosis and occupational silica exposure-a population-based study.

Authors:  H Englert; J Small-McMahon; K Davis; H O'Connor; P Chambers; P Brooks
Journal:  Aust N Z J Med       Date:  2000-04

2.  Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations.

Authors:  L D ERASMUS
Journal:  S Afr J Lab Clin Med       Date:  1957-09

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

Review 4.  Geoepidemiology of systemic sclerosis.

Authors:  Brigitte Ranque; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

5.  Association of occupational exposure with features of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Menard; Anne-Bénédicte Duval-Modeste; Pascal Joly; Stéphane Dominique; Pierre Bravard; David Noël; Jean-François Gehanno; Michael Bubenheim; Jacques Benichou; Hervé Levesque
Journal:  J Am Acad Dermatol       Date:  2015-01-10       Impact factor: 11.527

6.  Connective tissue disease and silicosis.

Authors:  K D Rosenman; M Moore-Fuller; M J Reilly
Journal:  Am J Ind Med       Date:  1999-04       Impact factor: 2.214

7.  Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis.

Authors:  M H Rustin; H A Bull; V Ziegler; J Mehlhorn; U F Haustein; P J Maddison; J James; P M Dowd
Journal:  Br J Dermatol       Date:  1990-12       Impact factor: 9.302

8.  Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis.

Authors:  Ashima Makol; Mary Jo Reilly; Kenneth D Rosenman
Journal:  Am J Ind Med       Date:  2010-10-18       Impact factor: 2.214

9.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

10.  Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.

Authors:  N J McHugh; J Whyte; G Harvey; U F Haustein
Journal:  Arthritis Rheum       Date:  1994-08
View more
  6 in total

1.  Three's Company: Coexistence of Silicosis, Scleroderma, and Sjogren Syndrome in a Single Patient.

Authors:  Alexis Ziebelman; Shir Raibman-Spector; Omer Gendelman
Journal:  Case Rep Rheumatol       Date:  2022-05-27

2.  Is exposure to environmental factors associated with a characteristic clinical and laboratory profile in systemic sclerosis? A retrospective analysis.

Authors:  Lisbeth A Aguila; Henrique Carriço da Silva; Ana Cristina Medeiros-Ribeiro; Bruna Giusto Bunjes; Ana Paula Luppino-Assad; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2020-08-30       Impact factor: 2.631

3.  Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease.

Authors:  Kathleen Biblowitz; Cathryn Lee; Daisy Zhu; Imre Noth; Rekha Vij; Mary E Strek; Shashi K Bellam; Ayodeji Adegunsoye
Journal:  ERJ Open Res       Date:  2021-11-08

Review 4.  Erasmus Syndrome: A Case Report and Literature Review.

Authors:  Jan Michael Jesse Lomanta; Mary Antonette Atienza; Juan Raphael M Gonzales; Eric Jason Bautista Amante; Sheen C Urquiza; Hanna Lucero-Orillaza; Joel Marquez Santiaguel
Journal:  Am J Case Rep       Date:  2022-08-10

5.  Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.

Authors:  Cathryn T Lee; Ayodeji Adegunsoye; Jonathan H Chung; Iazsmin Bauer Ventura; Renea Jablonski; Steven Montner; Rekha Vij; Stella E Hines; Mary E Strek
Journal:  Chest       Date:  2021-02-20       Impact factor: 10.262

Review 6.  Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies.

Authors:  Sakir Ahmed; Sarit Sekhar Pattanaik; Mohit Kumar Rai; Alok Nath; Vikas Agarwal
Journal:  Mediterr J Rheumatol       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.